Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ayelet
Ayelet Akselrod-Ballin, Kiryat Ono IL
| Patent application number | Description | Published |
|---|---|---|
| 20100260396 | INTEGRATED SEGMENTATION AND CLASSIFICATION APPROACH APPLIED TO MEDICAL APPLICATIONS ANALYSIS - A novel multiscale approach that combines segmentation with classification to detect abnormal brain structures in medical imagery, and demonstrate its utility in detecting multiple sclerosis lesions in 3D MRI data. The method uses segmentation to obtain a hierarchical decomposition of a multi-channel, anisotropic MRI scan. It then produces a rich set of features describing the segments in terms of intensity, shape, location, and neighborhood relations. These features are then fed into a decision tree-based classifier, trained with data labeled by experts, enabling the detection of lesions in all scales. Unlike common approaches that use voxel-by-voxel analysis, our system can utilize regional properties that are often important for characterizing abnormal brain structures. Experiments show successful detections of lesions in both simulated and real MR images. | 10-14-2010 |
Ayelet Barenholz, Jerusalem IL
| Patent application number | Description | Published |
|---|---|---|
| 20080318868 | Use of Mycobacterial Mannosylated Lipoglycans Peptide Mimotopes For Treating Inflammation - The present invention is based on the discovery that biological peptide-based mimotopes of mannose-containing cell-wall compounds of | 12-25-2008 |
Ayelet Chajut, Ramat Hasharon IL
| Patent application number | Description | Published |
|---|---|---|
| 20100035963 | Oligoribonucleotides and Methods of use Thereof for Treatment of Cardiovascular Disease - The invention relates to a double-stranded compound, preferably an oligoribonucleotide, which down-regulates the expression of one or more cardiovascular-related gene. The invention also relates to a pharmaceutical composition comprising the compound, or a vector capable of expressing the oligoribonucleotide compound, and a pharmaceutically acceptable carrier. The present invention also contemplates a method of treating a patient suffering from a cardiovascular disorder or other diseases comprising administering to the patient the pharmaceutical composition in a therapeutically effective dose so as to thereby treat the patient. | 02-11-2010 |
| 20100267814 | Targeting MicroRNAs for the Treatment of Liver Cancer - Provided herein are methods for the treatment of liver cancer. These methods encompass the administration of a compound comprising a modified oligonucleotide, wherein the modified oligonucleotide is targeted to a miRNA. Also provided herein are compositions for the treatment of liver cancer. Such compositions include compounds comprising a modified oligonucleotide, wherein the modified oligonucleotide is targeted to a miRNA. Certain miRNAs have been identified as overexpressed in liver cancer, such as, for example, hepatocellular carcinoma, and are thus selected for targeting by modified oligonucleotides. Further, certain miRNAs have been identified as overexpressed in hepatocellular carcinoma cells exposed to dioxin, and are thus selected for targeting by modified oligonucleotides. Antisense inhibition of certain of these miRNAs has been found to inhibit cell proliferation and induce apoptosis. | 10-21-2010 |
Ayelet Lesman, Haifa IL
| Patent application number | Description | Published |
|---|---|---|
| 20090169521 | Vascularized cardiac tissue and methods of producing and using same - An isolated composition of matter is disclosed. The composition comprises a heterogeneous population of cells seeded on a scaffold, wherein the heterogeneous population of cells comprises cardiomyocytes, endothelial cells and fibroblast cells. Pharmaceutical compositions comprising same and uses thereof are also disclosed. | 07-02-2009 |
Ayelet Mofar, Nes-Ziona IL
| Patent application number | Description | Published |
|---|---|---|
| 20110106067 | MULTI-APPLICATION SKIN CARE SYSTEM - A skin care device comprising a handle and swappable heads connected via a magnetic drive. Avoidance of a mechanical coupling between the handle and the head enhances safety. The magnetic power is converted to electrical power to operate the LEDs and anything else needing electrical power as well as mechanical forces releasing therapeutic cream upon the consumer's skin. The device may further apply RF to the skin for complementary treatment. Using the magnetic drives allows the transfer of power without using serrated gears and because there are no electrical connectors allows using swappable heads on the same handle in humid or wet conditions. The handle is charged inductively. | 05-05-2011 |
Ayelet Rubinovitch Trop, Bat-Chen IL
| Patent application number | Description | Published |
|---|---|---|
| 20110160618 | APPARATUS FOR THE DIAGNOSIS AND TREATMENT OF BRUXISM - The present invention is an apparatus for detecting and treating bruxism. The apparatus of the invention comprises a sensing unit, a calculation unit and a stimulation unit. The sensing unit is in charge of measuring the interocclusal distance and reporting this distance to the calculation unit. After receiving the information from the sensing unit, the calculation unit archives and processes the information to determine if the sensing event is a bruxism event. When a sensing event is confirmed as a bruxism event, the calculation unit selects an adequate stimulation and sends a request to the stimulation unit, which applies the selected stimulation. The apparatus of the present invention may be suitable for treating both diurnal and nocturnal bruxism and the intrabuccal components may be removed from the mouth when bruxism events are not expected to occur, i.e. during the day for an individual who suffers only from nocturnal bruxism. | 06-30-2011 |